Tourangeau Greg
- SEC CIK
- 0001916566
No open-market purchases or sales filed in the past year.
Current role at each company
- FULC Fulcrum Therapeutics, Inc.Principal Accounting Officeras of Feb 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Tourangeau Greg as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 9, 2025 (view filing) | May 8 | 1 day | Tourangeau GregPrincipal Accounting Officer | SSale | −498 | $5.06 | −$2.52K | −3.4%14.1K after | |
| May 9, 2024 (view filing) | May 7 | 2 days | Tourangeau GregPrincipal Accounting Officer | SSale | −236 | $7.76 | −$1.83K | −2.0%11.6K after | |
| Mar 8, 2024 (view filing) | Mar 8 | Same day | Tourangeau GregVice President, Finance | SSale | −4.88K | $11.72 | −$57.2K | −29.3%11.8K after | |
| May 11, 2023 (view filing) | May 10 | 1 day | Tourangeau GregPrincipal Accounting Officer | SSale | −210 | $3.31 | −$695.1 | −1.3%16.0K after |